Frans Duraj

823 total citations
38 papers, 633 citations indexed

About

Frans Duraj is a scholar working on Surgery, Hepatology and Transplantation. According to data from OpenAlex, Frans Duraj has authored 38 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 13 papers in Hepatology and 10 papers in Transplantation. Recurrent topics in Frans Duraj's work include Organ Transplantation Techniques and Outcomes (11 papers), Renal Transplantation Outcomes and Treatments (9 papers) and Clinical Nutrition and Gastroenterology (7 papers). Frans Duraj is often cited by papers focused on Organ Transplantation Techniques and Outcomes (11 papers), Renal Transplantation Outcomes and Treatments (9 papers) and Clinical Nutrition and Gastroenterology (7 papers). Frans Duraj collaborates with scholars based in Sweden, Germany and Finland. Frans Duraj's co-authors include Bo‐Göran Ericzon, Styrbjörn Friman, Lars Wikström, Ole B. Suhr, Gösta Holmgren, Carl G. Groth, Lars Steen, Agneta Norén, Gunnela Nordén and U Haglund and has published in prestigious journals such as Journal of Hepatology, Transplantation and American Journal of Transplantation.

In The Last Decade

Frans Duraj

37 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frans Duraj Sweden 14 238 197 189 144 108 38 633
Wladyslaw Gedroyc United Kingdom 9 104 0.4× 136 0.7× 118 0.6× 109 0.8× 39 0.4× 12 586
Belinda Sánchez Pérez Spain 15 310 1.3× 248 1.3× 144 0.8× 150 1.0× 57 0.5× 89 809
Dagmar Kollmann Austria 18 472 2.0× 286 1.5× 86 0.5× 118 0.8× 126 1.2× 48 761
Zhenhua Hu China 17 278 1.2× 247 1.3× 252 1.3× 263 1.8× 56 0.5× 64 1.0k
J Cinqualbre France 16 540 2.3× 358 1.8× 86 0.5× 177 1.2× 60 0.6× 77 837
A. Zeevi United States 18 311 1.3× 53 0.3× 135 0.7× 67 0.5× 253 2.3× 36 748
Jaime Glorioso United States 13 269 1.1× 330 1.7× 128 0.7× 200 1.4× 53 0.5× 24 595
M. Golling Germany 19 556 2.3× 471 2.4× 66 0.3× 243 1.7× 86 0.8× 87 1.1k
Christopher Burghuber Austria 14 304 1.3× 114 0.6× 49 0.3× 82 0.6× 317 2.9× 26 614
Anna L. Taylor United Kingdom 9 284 1.2× 54 0.3× 77 0.4× 185 1.3× 343 3.2× 10 960

Countries citing papers authored by Frans Duraj

Since Specialization
Citations

This map shows the geographic impact of Frans Duraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frans Duraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frans Duraj more than expected).

Fields of papers citing papers by Frans Duraj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frans Duraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frans Duraj. The network helps show where Frans Duraj may publish in the future.

Co-authorship network of co-authors of Frans Duraj

This figure shows the co-authorship network connecting the top 25 collaborators of Frans Duraj. A scholar is included among the top collaborators of Frans Duraj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frans Duraj. Frans Duraj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Dubbelboer, Ilse R., Rimma Axelsson, Torkel B. Brismar, et al.. (2016). In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma. Molecular Pharmaceutics. 14(2). 448–458. 26 indexed citations
3.
Aandahl, Einar Martin, William Bennet, Michael Olausson, et al.. (2015). Transplantation With Livers From Deceased Donors Older Than 75 Years. Transplantation. 99(12). 2534–2542. 22 indexed citations
5.
Norén, Agneta, et al.. (2010). Longterm follow-up after transarterial chemotherapy for hepatocellular carcinoma in a Scandinavian centre. HPB. 12(9). 637–643. 8 indexed citations
6.
Yamamoto, Shinji, H Wilczek, Frans Duraj, C. G. Groth, & B.‐G. Ericzon. (2010). Liver Transplantation with Grafts from Controlled Donors after Cardiac Death: A 20‐Year Follow‐up at a Single Center. American Journal of Transplantation. 10(3). 602–611. 33 indexed citations
7.
Haglund, U, et al.. (2008). Right Hemihepatectomy. Journal of Gastrointestinal Surgery. 12(7). 1283–1287. 3 indexed citations
8.
Melum, Espen, Styrbjörn Friman, Kristian Bjøro, et al.. (2007). Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma. Journal of Hepatology. 47(6). 777–783. 24 indexed citations
9.
Herlenius, Gustaf, Marie Krantz, Yigael Finkel, et al.. (2004). [Intestinal transplantation--an experimental therapy which has become a realistic alternative].. PubMed. 101(38). 2874–8. 2 indexed citations
10.
Wu, Guosheng, et al.. (2000). The living-related small bowel transplant: the first case in China. Transplantation Proceedings. 32(6). 1218–1218. 4 indexed citations
11.
Söderdahl, Gunnar, et al.. (1998). Ursodeoxycholic acid increased bile flow and affects bile composition in the early postoperative phase following liver transplantation. Transplant International. 11(7). S231–S238. 11 indexed citations
12.
Barkholt, Lisbeth, Jan Andersson, Bo‐Göran Ericzon, et al.. (1997). Stool cultures obtained before liver transplantation are useful for choice of perioperative antibiotic prophylaxis. Transplant International. 10(6). 432–438. 8 indexed citations
13.
Jacobson, Stefan H., Georg Jaremko, Frans Duraj, & H Wilczek. (1996). Renal fibrosis in cyclosporin A-treated renal allograft recipients: morphological findings in relation to renal hemodynamics. Transplant International. 9(5). 492–498. 10 indexed citations
14.
Jacobson, Stefan H., Georg Jaremko, Frans Duraj, & H Wilczek. (1996). Renal fibrosis in cyclosporin A-treated renal allograft recipients: morphological findings in relation to renal hemodynamics. Transplant International. 9(5). 492–498. 1 indexed citations
15.
Söderdahl, Gunnar, et al.. (1995). FK 506 improves recovery of bile secretion following orthotopic liver transplantation in man.. PubMed. 27(1). 1125–1125. 3 indexed citations
16.
Duraj, Frans, et al.. (1995). Hepatic malignancies, a controversial indication for liver replacement: 10 year experience from a Scandinavian center.. PubMed. 27(6). 3495–6. 1 indexed citations
17.
Duraj, Frans, et al.. (1995). Living-donor nephrectomy: how safe is it?. PubMed. 27(1). 803–4. 8 indexed citations
18.
Duraj, Frans, et al.. (1991). Serum levels of alpha-1 microglobulin and beta-2 microglobulin in bone marrow transplant recipients treated with cyclosporin A. Transplant International. 4(3). 146–150. 7 indexed citations
19.
Lindholm, Anders, et al.. (1991). Long-term renal allograft function under maintenance immunosuppression with cyclosporin A or azathioprine. Transplant International. 4(3). 166–172. 6 indexed citations
20.
Tollemar, J, Frans Duraj, & B.-G. Ericzon. (1990). Liposomal amphotericin B treatment in a 9‐month‐old liver recipient. Mycoses. 33(5). 251–252. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026